Synthesis and Anticancer Properties of New 3-Methylidene-1-sulfonyl-2,3-dihydroquinolin-4(1


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
03 Jun 2022
Historique:
received: 01 04 2022
revised: 21 04 2022
accepted: 01 06 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Quinolinones have been known for a long time as broad-spectrum synthetic antibiotics. More recently, the anticancer potential of this group of compounds has been investigated. Following this direction, we obtained a small library of 3-methylidene-1-sulfonyl-2,3-dihydroquinolin-4(1

Identifiants

pubmed: 35684532
pii: molecules27113597
doi: 10.3390/molecules27113597
pmc: PMC9181899
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Quinolones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Center of Research and Development (Warsaw, Poland) in the framework of project In-terChemMed
ID : POWR.03.02.00-00-I029/16
Organisme : Medical University of Lodz
ID : 503/1-156-02/503-11-001-19-00

Références

Oncogene. 2003 Nov 24;22(53):8543-67
pubmed: 14634618
Anal Biochem. 1999 May 15;270(1):41-9
pubmed: 10328763
J Antimicrob Chemother. 2003 May;51 Suppl 1:13-20
pubmed: 12702699
Cytometry B Clin Cytom. 2008 May;74(3):163-8
pubmed: 18200595
Trends Mol Med. 2006 Sep;12(9):440-50
pubmed: 16899408
Eur J Med Chem. 2015 Jun 5;97:397-408
pubmed: 25532473
Phytother Res. 2021 Mar;35(3):1432-1442
pubmed: 33058354
J Nat Prod. 2016 Feb 26;79(2):300-7
pubmed: 26848627
Curr Pharm Des. 2016;22(30):4705-4716
pubmed: 26932159
Chem Biodivers. 2018 Sep;15(9):e1800242
pubmed: 29935105
Arch Pharm (Weinheim). 2019 Jul;352(7):e1800376
pubmed: 31215674
J Nat Prod. 2014 May 23;77(5):1117-22
pubmed: 24798019
Environ Toxicol Pharmacol. 2021 Jan;81:103513
pubmed: 33091599
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
Chemistry. 2012 Dec 7;18(50):15922-6
pubmed: 23154811
Curr Pharm Des. 2016;22(39):6009-6020
pubmed: 27426131
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Mini Rev Med Chem. 2007 Feb;7(2):131-9
pubmed: 17305587
Molecules. 2016 Mar 28;21(4):268
pubmed: 27043501
Bioorg Med Chem. 2014 Jan 1;22(1):105-15
pubmed: 24332654
Drug Discov Today. 2012 Jun;17(11-12):561-72
pubmed: 22309965

Auteurs

Agata Jaskulska (A)

Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.

Katarzyna Gach-Janczak (K)

Department of Biomolecular Chemistry, Faculty of Medicine, Medicinal University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Joanna Drogosz-Stachowicz (J)

Department of Biomolecular Chemistry, Faculty of Medicine, Medicinal University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Tomasz Janecki (T)

Institute of Organic Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.

Anna Ewa Janecka (AE)

Department of Biomolecular Chemistry, Faculty of Medicine, Medicinal University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH